Drug
Lesinurad 400 mg
Lesinurad 400 mg is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Antacid Interaction Study
NCT01982201
completedphase_1
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
NCT02039700
completedphase_1
Metformin and Furosemide Drug-Drug Interaction Study
NCT02028689
completedphase_1
Lesinurad Interaction Study With Ranitidine
NCT01908257
completedphase_1
NSAID Drug Interaction Study
NCT01884272
Clinical Trials (5)
Showing 5 of 5 trials
NCT01982201Phase 1
Antacid Interaction Study
NCT02039700Phase 1
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
NCT02028689Phase 1
Metformin and Furosemide Drug-Drug Interaction Study
NCT01908257Phase 1
Lesinurad Interaction Study With Ranitidine
NCT01884272Phase 1
NSAID Drug Interaction Study
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5